Reuters logo
BRIEF-Chimerix announces final data from advise trial of brincidofovir at BMT Tandem meetings
February 22, 2017 / 1:19 PM / 7 months ago

BRIEF-Chimerix announces final data from advise trial of brincidofovir at BMT Tandem meetings

Feb 22 (Reuters) - Chimerix Inc

* Chimerix announces final data from advise trial of brincidofovir at BMT Tandem meetings

* Chimerix Inc says results show higher survival rate in adenovirus-infected patients with a virologic response to brincidofovir

* Chimerix Inc says mortality rates were lower in pediatric patients than in adult patients Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below